RecruitingNCT05438511

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

85 participants

Start Date

Apr 13, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is not a treatment trial. Instead, it is a qualitative research study in Tanzania aimed at improving how breast cancer is tested and diagnosed. Specifically, it focuses on improving hormone receptor testing (which determines if a cancer can be treated with hormone-blocking drugs) by interviewing healthcare workers and patients to understand current barriers and how to fix them. **You may be eligible if:** - You are a breast cancer survivor, patient advocate, or healthcare worker involved in breast cancer care in Tanzania - You have worked at your institution for more than 12 months (for healthcare staff) - You are a permanent resident or citizen of Tanzania - You speak Swahili and/or English **You may NOT be eligible if:** - You are a healthcare worker not currently based at the affiliated institution during the data collection period Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFocus group

A semi-structured focus group discussion guide will be developed with question probes that cover 1) contextual factors, 2) barriers to implementation, and 3) facilitators to implementation, with secondary probing questions.

BEHAVIORALOrganizational Readiness for Implementing Change

measures the extent to which organizational members are prepared to implement organizational change. The ORIC tool asks participants to rate their level of agreement with 12 statements pertaining to organizational readiness for change (change commitment and change efficacy) on a 5-point Likert Scale.


Locations(2)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Muhimbili University of Health and Allied Sciences

Dar es Salaam, Tanzania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05438511


Related Trials